Triceps Surae Trigger Point Size and Muscle Extensibility
NCT ID: NCT02087969
Last Updated: 2017-12-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2014-04-30
2015-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dry Needling
Dry Needling to Triceps Surae
Dry Needling
Stretching
Subjects will be given a home exercise program of stretches which are commonly prescribed to improve ankle dorsiflexion.
Stretching
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dry Needling
Stretching
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-30 Years Old
* No history of ankle surgery
* No current ankle injuries
Exclusion Criteria
* fibromyalgia
* connective tissue disorders
* chronic pain
* bleeding disorders including use of anti-coagulants
* vitamin D and B12 deficiencies
* active sites of cancer
* local or systemic infections
* local skin lesions, local lymphedema
* peripheral vascular disease including varicose veins
* compromised immune system
* needle phobia
18 Years
30 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Duke University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chad Cook, PhD, PT
Role: PRINCIPAL_INVESTIGATOR
Duke University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Duke Sports Medicine
Durham, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00052299
Identifier Type: -
Identifier Source: org_study_id